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The patient was a body builder ( Figure 1 ) and had been actively training for the past 10 years. He admitted to taking anabolic steroids over this time period (see Table 1 ). He had a positive family history of hypertension. Ambulatory blood pressure monitoring ( Figure 2 ) revealed severe systolic and diastolic hypertension, with preservation of the normal nocturnal dipping pattern. A work-up for target organ damage showed severe concentric left ventricular hypertrophy (Figure 3 ) on echocardiography, with a calculated left ventricular mass of 661 grams. He also had mild left atrial enlargement. The serum HDL cholesterol was 0.66 mmol/l, and the LDL fraction was 4.97 mmol/l. In view of the severity of the pressure elevation he underwent evaluation for an underlying primary cause for his hyper- 
Discussion
Anabolic steroid use is associated with a number of cardiovascular side effects. 1 Hypertension, 2 left ventricular hypertrophy, 3 and dyslipidaemia 4 have all been described. Whilst physical isometric training produces a physiological hypertrophy of the left ventricle, 5 it has been found that androgenic hormone use in the context of weight training produces pathological remodelling, 6 with an increase in the fibrous collagen component of the hypertrophied myocardium. This may lead to both a reduced compliance and an increased risk of sudden death and myocardial failure. 7, 8 Regression of LVH may occur in patients after discontinuation of steroid use, but the loss of compliance and reduced inotropism of the ventricle may not recover. 9 The degree of hypertrophy of the myocardium in this man's case was considerably larger than that reported in similar cases, and the absence of asymetrical septal hypertrophy or abnormal mitral valve function renders unlikely coincidental hypertrophic obstructive cardiomyopathy.
Dyslipidaemia has been described in the context of anabolic steroid abuse. 4 The form typically ascribed is an elevation of LDL cholesterol and a reduction in HDL cholesterol. Cases of severe coronary atherosclerosis in subjects taking these drugs 10 may well be a reflection of an atherogenic lipid pattern. 
